Drug Type siRNA |
Synonyms BP-100-2.01, BP-101-2.01 |
Target |
Mechanism PTK2b gene inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Discovery | US | - | |
Ovarian Cancer | Discovery | US | - | |
Thyroid Cancer | Discovery | US | - |